| Primary |
| Hepatitis C |
86.4% |
| Product Used For Unknown Indication |
2.8% |
| Drug Use For Unknown Indication |
2.5% |
| Prophylaxis |
1.4% |
| Hypertension |
1.1% |
| Hepatitis |
0.7% |
| Chronic Hepatitis C |
0.5% |
| Thrombocytopenia |
0.5% |
| Hyperlipidaemia |
0.5% |
| Insomnia |
0.5% |
| Hepatitis B |
0.4% |
| Malignant Melanoma |
0.4% |
| Drug Exposure During Pregnancy |
0.3% |
| Depression |
0.3% |
| Pain |
0.3% |
| Hepatic Cirrhosis |
0.3% |
| Nausea |
0.3% |
| Anaemia |
0.3% |
| Diabetes Mellitus |
0.3% |
| Iron Deficiency Anaemia |
0.3% |
|
| Weight Decreased |
21.6% |
| White Blood Cell Count Decreased |
19.7% |
| Vomiting |
16.9% |
| Pyrexia |
5.2% |
| Anaemia |
4.4% |
| Nausea |
3.4% |
| Platelet Count Decreased |
3.2% |
| Rash |
2.9% |
| Death |
2.5% |
| Tremor |
2.3% |
| Thrombocytopenia |
2.3% |
| Weight Increased |
2.3% |
| Pain |
2.1% |
| Malaise |
1.8% |
| Urinary Tract Infection |
1.8% |
| Fatigue |
1.7% |
| Suicidal Ideation |
1.6% |
| Red Blood Cell Count Decreased |
1.5% |
| Haemoglobin Decreased |
1.4% |
| Vision Blurred |
1.4% |
|
| Secondary |
| Hepatitis C |
67.8% |
| Product Used For Unknown Indication |
7.1% |
| Prophylaxis |
5.8% |
| Drug Use For Unknown Indication |
3.9% |
| Hypertension |
2.7% |
| Chronic Hepatitis C |
1.6% |
| Hyperlipidaemia |
1.5% |
| Hiv Infection |
1.5% |
| Thrombocytopenia |
1.3% |
| Insomnia |
0.9% |
| Iron Deficiency Anaemia |
0.8% |
| Depression |
0.8% |
| Diabetes Mellitus |
0.8% |
| Constipation |
0.5% |
| Chronic Hepatitis |
0.5% |
| Pyrexia |
0.5% |
| Rash |
0.5% |
| Hepatitis |
0.5% |
| Pain |
0.5% |
| Metastatic Malignant Melanoma |
0.5% |
|
| White Blood Cell Count Decreased |
16.7% |
| Weight Decreased |
14.3% |
| Vomiting |
10.0% |
| Anaemia |
8.9% |
| Rash |
6.2% |
| Haemoglobin Decreased |
4.9% |
| Platelet Count Decreased |
4.5% |
| Pyrexia |
4.0% |
| Thrombocytopenia |
3.6% |
| Neutropenia |
3.4% |
| Nausea |
3.1% |
| Suicidal Ideation |
2.9% |
| Neutrophil Count Decreased |
2.8% |
| Fatigue |
2.5% |
| Decreased Appetite |
2.2% |
| Malaise |
2.2% |
| Retinopathy |
2.1% |
| Pancytopenia |
2.0% |
| Renal Impairment |
2.0% |
| Tremor |
2.0% |
|
| Concomitant |
| Hepatitis C |
88.2% |
| Product Used For Unknown Indication |
2.3% |
| Hiv Infection |
2.2% |
| Hypertension |
1.3% |
| Adverse Event |
0.8% |
| Prophylaxis |
0.6% |
| Hyperuricaemia |
0.6% |
| Pain |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Depression |
0.4% |
| Prophylaxis Against Transplant Rejection |
0.4% |
| Gastritis |
0.4% |
| Paternal Drugs Affecting Foetus |
0.3% |
| Plasmacytoma |
0.2% |
| Anaemia |
0.2% |
| Arrhythmia |
0.2% |
| Cryoglobulinaemia |
0.2% |
| Pre-existing Disease |
0.2% |
| Back Pain |
0.2% |
| Chronic Hepatitis |
0.2% |
|
| Neutrophil Count Decreased |
15.9% |
| Rash |
9.8% |
| Anaemia |
9.4% |
| White Blood Cell Count Decreased |
8.0% |
| Decreased Appetite |
6.8% |
| Haemoglobin Decreased |
6.2% |
| Drug Eruption |
5.0% |
| Hyperuricaemia |
4.5% |
| Renal Impairment |
4.5% |
| Erythema Multiforme |
3.8% |
| Platelet Count Decreased |
3.6% |
| Nausea |
3.5% |
| Erythema |
3.1% |
| Blood Creatinine Increased |
2.8% |
| Renal Disorder |
2.7% |
| Pruritus |
2.2% |
| Vomiting |
2.2% |
| Toxic Skin Eruption |
2.1% |
| Malaise |
1.9% |
| Rash Generalised |
1.8% |
|
| Interacting |
|
| Drug Exposure Before Pregnancy |
50.0% |
| Drug Interaction |
50.0% |
|
